Title
Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults
Date Issued
01 September 2017
Access level
open access
Resource Type
journal article
Publisher(s)
International Union against Tubercul. and Lung Dis.
Abstract
INTRODUCTION: Few studies have described the prevalence of and lung function decline among those with a restrictive spirometric pattern (RSP) in low- and middleincome countries.METHODS: We analyzed prospective data from 3055 adults recruited across four diverse settings in Peru over a 3-year period. Multivariable logistic regression was used to study the association between the presence of restriction and associated risk factors. Multivariable linear mixed models were used to determine lung function decline.RESULTS: Among 3055 participants, the average age was 55.4 years (SD 12.4); 49% were male. Overall prevalence of RSP was 4.7%, ranging from 2.8% (Lima) to 6.9% (Tumbes). The odds of having RSP were higher among those who lived in a rural environment (OR 2.19, 95%CI 1.43-3.37), had a diagnosis of diabetes (OR 1.94, 95%CI 1.10-3.40) and among women (OR 2.09, 95%CI 1.41-3.09). When adjusting for baseline lung function, adults with RSP had accelerated decline in forced expiratory volume in 1 s (FEV1) compared with non-obstructed, non-restricted individuals. D I SCUS S ION: RSP is prevalent particularly among women and in individuals living in rural settings of Peru. When adjusted for baseline lung function, participants with RSP had accelerated rates of FEV1 decline.Our findings are consistent with the notion that RSP is an insidious inflammatory condition with deleterious effects of lung function decline.
Start page
1062
End page
1068
Volume
21
Issue
9
Language
English
OCDE Knowledge area
Sistema respiratorio
Scopus EID
2-s2.0-85028067358
PubMed ID
Source
International Journal of Tuberculosis and Lung Disease
ISSN of the container
10273719
Sponsor(s)
This project has been funded in whole with Federal funds from the United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA, under Contract No. HHSN268200900033C. WC was further supported by a Pathway to Independence Award (R00HL096955) from the National Heart, Lung and Blood Institute. Conflicts of interest: none declared.
Sources of information: Directorio de Producción Científica Scopus